Position in ALNY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$24,703,084
+$1,232,986 QoQ
Shares Held
74,661
+26.5% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
15 quarters on record
Voting authority
Sole 79.88508056414996.ToString("F0")%
Shared 20.11491943585004.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Derivatives in ALNY
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$1,566,116
PutShares
5,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026LMR Partners LLP holds $223,407,665 across 59 Biotechnology names. ALNY ranks #1 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
74,661 | $24,703,084 | |
| 2 | ACLX |
Arcellx, Inc.
|
212,495 | $24,398,675 | |
| 3 | TERN |
Terns Pharmaceuticals, Inc.
|
400,000 | $21,088,000 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
324,939 | $18,355,804 | |
| 5 | ARGX |
Argenx SE
|
23,488 | $17,152,112 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
403,622 | $16,237,713 | |
| 7 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,049,700 | $15,178,662 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
130,000 | $12,642,500 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,703,084 | 74,661 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $23,470,098 | 59,022 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $2,430,180 | 9,000 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $1,566,116 | 5,800 | Put | Sole | 2025-05-15 | |
| 2024-12-31 | $2,800,424 | 11,901 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $18,561,499 | 67,489 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,179,953 | 8,971 | Shares | Other | 2024-08-14 | |
| 2024-06-30 | $26,705,700 | 109,900 | Put | Other | 2024-08-14 | |
| 2024-06-30 | $51,491,700 | 211,900 | Call | Other | 2024-08-14 | |
| 2024-03-31 | $14,825,440 | 99,200 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $10,666,395 | 71,371 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $7,562,170 | 50,600 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $57,423 | 300 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $10,852,947 | 56,700 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $5,397,762 | 28,200 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,041,570 | 56,700 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $53,130 | 300 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $11,993,920 | 67,724 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $56,982 | 300 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $6,589,968 | 34,695 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $17,455,486 | 91,900 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $4,235,566 | 21,144 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $822,057 | 4,107 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,181,702 | 138,373 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $15,041,295 | 92,114 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,769,424 | 22,228 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||